Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
1.100
+0.138 (14.38%)
At close: Apr 17, 2026, 4:00 PM EDT
1.090
-0.010 (-0.91%)
After-hours: Apr 17, 2026, 7:58 PM EDT

Senti Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
343217306264
Market Cap Growth
-58.96%89.47%-43.80%-51.45%-2.54%-
Enterprise Value
46.4139.2622.6727.77-1.33200.54
Last Close Price
1.101.043.516.6014.1098.60
PE Ratio
--0.38-0.29-0.35-0.63-0.52
PS Ratio
1557.221459.75-11.7814.5023.09
PB Ratio
6.080.090.050.450.49-0.57
P/TBV Ratio
0.070.060.050.440.29-0.26
P/FCF Ratio
--0.74-0.41-0.47-0.81-1.59
P/OCF Ratio
--0.74-0.41-0.58-1.78-1.84
EV/Sales Ratio
2109.771784.34-10.84-0.3172.63
EV/EBITDA Ratio
--0.60-0.40-0.320.02-5.36
EV/EBIT Ratio
--0.57-0.37-0.300.02-4.96
EV/FCF Ratio
--0.90-0.55-0.430.02-4.99
Debt / Equity Ratio
0.060.060.080.500.280.35
Debt / EBITDA Ratio
-0.44-0.44-0.59-0.43-0.64-0.61
Debt / FCF Ratio
-0.66-0.66-0.81-0.58-0.49-0.57
Net Debt / Equity Ratio
0.030.03-0.050.03-0.480.30
Net Debt / EBITDA Ratio
-0.19-0.190.26-0.021.060.89
Net Debt / FCF Ratio
-0.29-0.290.36-0.030.810.83
Asset Turnover
0.000.0000.020.030.04
Quick Ratio
1.291.293.814.325.493.89
Current Ratio
1.671.674.495.625.684.14
Return on Equity (ROE)
-17.26%-17.26%-25.45%-85.91%-52.94%-121.10%
Return on Assets (ROA)
-92.28%-92.28%-56.17%-61.76%-44.75%-55.77%
Return on Invested Capital (ROIC)
-201.61%-201.61%-103.36%-128.20%-126.14%-179.58%
Return on Capital Employed (ROCE)
-112.80%-112.80%-63.75%-68.80%-50.70%-64.39%
Earnings Yield
-179.33%-262.50%-342.74%-284.85%-158.16%-192.70%
FCF Yield
-127.38%-135.89%-244.38%-213.63%-122.76%-63.02%
Buyback Yield / Dilution
-389.20%-389.20%-3.58%-69.93%-796.58%-
Total Shareholder Return
-389.20%-389.20%-3.58%-69.93%-796.58%-
Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q